Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.13
+0.67 (2.63%)
At close: Oct 27, 2026, 4:00 PM EDT
25.76
-0.37 (-1.42%)
After-hours: Oct 27, 2026, 7:31 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.69 billion as of October 27, 2026. It is the 7,362nd most valuable company in the world and the 1,887th biggest in the United States. Its market cap has decreased by 4.68% in one year.
Market Cap
1.69B
Enterprise Value
1.33B
1-Year Change
-4.68%
Global Rank
Country Rank
#1,887 United States
Category
ChartMarket Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.69B, an increase of 109.59%. That is a compound annual growth rate of 10.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.69B | -7.00% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemab Therapeutics Holdings | 1.68B |
| UroGen Pharma | 1.66B |
| Kailera Therapeutics | 1.66B |
| Mesoblast | 1.64B |
| Absci | 1.62B |
| Immunocore Holdings | 1.61B |
| Generate Biomedicines | 1.59B |
| Nuvation Bio | 1.58B |